CA Patent

CA3005090A1 — Compositions and methods for treatment of liver diseases

Assigned to Cold Spring Harbor Laboratory · Expires 2017-06-22 · 9y expired

What this patent protects

Provided herein are methods and compositions for increasing the expression of a protein, and for treating a subject in need thereof, e.g., a subject with deficient protein expression or a subject having a liver disease.

USPTO Abstract

Provided herein are methods and compositions for increasing the expression of a protein, and for treating a subject in need thereof, e.g., a subject with deficient protein expression or a subject having a liver disease.

Drugs covered by this patent

Patent Metadata

Patent number
CA3005090A1
Jurisdiction
CA
Classification
Expires
2017-06-22
Drug substance claim
No
Drug product claim
No
Assignee
Cold Spring Harbor Laboratory
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.